Vir Biotechnology, Inc. (VIR) NASDAQ
8.74
-0.29(-3.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.74
-0.29(-3.21%)
Currency In USD
| Market Cap | 835.28M |
| Enterprise Value | 788.08M |
| P/E Ratio | -2.91 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 22.51 |
| Price/Book Ratio | 1.58 |
| Enterprise/Revenue | 19.61 |
| Enterprise/EBITDA | -2.88 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -6.76 |
| Operating Margin | -7.05 |
| Return On Assets | -0.43 |
| Return On Equity | -0.53 |
| Revenue | 68.56M |
| Revenue/Share | 0.44 |
| Gross Profit | 56.85M |
| EBITDA | -426.09M |
| Net Income | -437.99M |
| Diluted EPS | -3.16 |
| Total Cash | 472.36M |
| Total Cash/Share | 3.21 |
| Total Debt | 86.64M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 7.11 |
| Book Value Per Share | 5.52 |
| 52-Week Change | 67.11 |
| 52-Week High | 11.66 |
| 52-Week Low | 4.16 |
| Moving Average 50 Days | 9.53 |
| Moving Average 200 Days | 7.21 |
| Average Volume | 2.03M |
| Shares Outstanding | 168.65M |
| % Held by Institutions | 100.18 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |